Rxsight’s Heavy Reliance on Alcon Poses Key Commercial and Royalty Risks
at www.tipranks.com (Thu, 5-Nov 1:01 AM)
Market Chameleon (Wed, 4-Nov 11:54 AM)
Analysts Have Conflicting Sentiments on These Healthcare Companies: RxSight (RXST) and Ocugen (OCGN)
at www.tipranks.com (Wed, 4-Nov 4:30 PM)
RxSight’s Weak Q3 and Uncertain Recovery Path Warrant a Hold Rating
at www.tipranks.com (Wed, 4-Nov 8:44 AM)
RxSight Non-GAAP EPS of -$0.21 misses by $0.02, revenue of $24.6M misses by $2.59M
at seekingalpha.com (Tue, 3-Nov 4:35 PM)
